ACHIEVING HCV ELIMINATION Improving Outcomes in the Treatment of Opioid Dependence (IOTOD), 16th Annual Meeting, 15./16.05.2018, Madrid, Spanien http://www.iotodeducation.com/wp-content/uploads/2018/06/IOTOD_2018_HCV_REPORT_v1.0.pdf

Hepatitis D Viremia Among Injection Drug Users in San Francisco. Mahale P, Aka PV, Chen X, Liu P, Fram BJ, Wang AS, Simenel S, Tseng FC, Chen S, Edlin BR, Glenn JS, O'Brien TR. J Infect Dis. 2018 May 25;217(12):1902-1906. doi: 10.1093/infdis/jiy15…

Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study. Sundberg I, Lannergård A, Ramklint M, Cunningham JL. BMC Psychiatry. 2018 May 29;18(1)…

Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study. Lanini S, Scognamiglio P, Mecozzi A, Lombardozzi L, Vullo V, Angelico M, Gasbarrini A, Taliani G, Attili AF, Perno CF, De Santis A, Puro V, Cerqua F, D'Off…

Hepatitis C coinfection adversely affects the life expectancy of people living with HIV in northwestern Poland. Leszczyszyn-Pynka M, Ciejak P, Maciejewska K, Witak-Jędra M, Karasińska-Cieślak M, Karpińska E, Wawrzynowicz-Syczewska M, Parczewski M…

Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village. Ahmed OA, Safwat E, Khalifa MO, Elshafie AI, Fouad MHA, Salama MM, Naguib GG, Eltabba…